drugset

drugset / Trial / NCT00326586

A Phase I Dose-Escalation Study of BMS-641988 in Patients With Castration-Resistant Prostate Cancer

NCT00326586 ↗

Phase 1 Completed 54 enrolled Bristol-Myers Squibb

RandomizedCrossoverDouble-blindTreatment

Summary

This is a Phase I Dose-Escalation Study of BMS641988 in Patients with Castration-Resistant Prostate Cancer.

Timeline

Start: 2006-05
Primary completion: 2009-03
Completion: 2009-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	BMS-641988	Unknown	—	Oral

Indications